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INTRODUCTION
Infantile hemangioma (IH), which is a benign neoplasm of vas­
cular endothelial cells, is the most common tumor that affects 
children [1]. Moreover, it is the most common lesion clinically 
diagnosed among newborns, with an occurrence rate of 4%–10% 
[2]. Hemangiomas are characterized by distinct phases of prolif­
eration and regression, involving changes in the balance between 
proliferation and apoptosis in vascular endothelial cells. In the 
first phase, known as the proliferating period, the tumor pro­
gresses rapidly due to excessive endothelial cell proliferation 
over the course of six to ten months. The involuting phase fol­
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lows, which lasts for seven years. During this phase, endothelial 
cell hyperplasia is reduced and apoptosis increases, leading to 
spontaneous regression. At approximately the age of 10 years, 
the tumor enters its final phase, known as the involuted phase, 
which eventually involves complete regression, which is marked 
by the replacement of blood vessels with fibrofatty tissue [3]. 
Most hemangiomas remain relatively small and do not pose sig­
nificant clinical problems. However, in a small number of pati­
ents, the tumors may grow rapidly to a size that can be problem­
atic and even life­threatening. Moreover, 40%–80% of IHs leave 
a permanent scar or a mass of fat after the involution of the tu­
mor, which can be pose significant aesthetic problems for chil­
dren with facial lesions [4].
The extracellular matrix (ECM) plays a fundamental role in 
supporting the vascular endothelium. Primarily through adhe­
sive interactions with endothelial cell integrins, ECM compo­
nents provide the scaffolding that allows vascular endothelial 
cells to be organized into blood vessels. The diversity of ECM 
components in the endothelial cell microenvironment and of 
the mechanisms that regulate the synthesis and degradation of 
ECM components suggests that the ECM is sufficiently com­
plex to exert significant and precise control over many aspects of 
neovascularization and blood vessel maturation [5].
The interactions between the ECM and cells, mediated by in­
tegrins on the endothelial surface, provide crucial environmen­
tal signals to endothelial cells that potentially control angiogen­
esis. The induction of vascular permeability through the loss of 
cellular adhesion, cell migration, and the secretion of proteolytic 
enzymes provides plasma­borne matrix molecules with access 
to extracellular spaces. Thus, the composition of the ECM may 
vary between sites of vascular formation and active angiogenesis.
In one study, changes of the ECM environment were observed 
between the phases of IH and were associated with angiogenic 
growth, suggesting a causal link between angiogenesis and chan­
ges in the ECM composition [6]. Although all cases in this re­
port showed a significantly higher level of some elements involv­
ed in the regulation of angiogenesis, those observations were 
not directly linked with a change of phase. The observation of 
changes in the ECM composition raises the question of its role 
in the transition between the proliferating and involuted stages, 
as well as the question of which characteristics of the ECM com­
position might predict the phase of an IH. We therefore exam­
ined the composition of the ECM in the proliferating and invo­
luted phases of IHs. The aim of this study was to evaluate differ­
ences in the ECM environment between proliferating and invo­
luted IHs, with the ultimate goal of discovering how the compo­
sition of the ECM is associated with the transition between the 
phases of IHs.
METHODS
Tissue sampling
Hemangioma tissues were obtained via surgical excision in 10 
patients, reflecting the proliferative phase of IH (n = 5, patients 
aged 3–11 months) and the involuted phase of IH (n = 5, pa­
tients aged 5.5–8.5 years). None of the children had received 
pharmacological therapy. All patients provided informed con­
sent, and the study was conducted in accordance with the ethi­
cal guidelines of the Helsinki Declaration and received approval 
from the Institutional Review Board (KNU 2015­0055)”. Chart 
review was combined with histological findings to determine 
whether the hemangiomas were in the proliferative or involuted 
phase. 
Enzyme-linked immunosorbent assay
Enzyme­linked immunosorbent assay (ELISA) kits capable of 
determining collagen type I, II, III, fibronectin, and laminin lev­
els were used on the proliferative and involuted IH tissue sam­
ples. ELISA was performed using kits for human collagen type I 
(Chondrex Inc., Redmond, Washington, USA), human collagen 
types II and III, laminin (USCN Life Science Inc., Wuhan, Hu­
bei, China) and human fibronectin (Millipore Corp. Inc., Darm­
stadt, Hesse, Germany) in accordance with the manufacturer’s 
instructions, 1 μg of protein in 100 μL of diluent was used to 
normalize the protein content across all samples. All samples 
were assayed in duplicate and the absorbance was then mea­
sured using an ELISA analyzer at 450 nm. Statistical analysis 
was performed using the Mann­Whitney U test, with the signifi­
cance level set at 0.05. 
Immunohistochemistry
All tissues obtained from the 10 patients were 10% phosphate­
buffered, formalin­fixed, and paraffin­embedded. The tissues 
were processed, cut at a thickness of 4 μm, stained with hema­
toxylin­eosin and Masson’s trichrome, and evaluated by light 
microscopy. In addition, immunohistochemical staining with 
collagen type III, laminin α4, and laminin α5 antibodies was 
performed to evaluate expression patterns in the ECM compo­
sition of all hemangioma tissue samples. Tissue sections were 
cut at a thickness of 4 μm and placed on Probe on Plus micro­
scope slides (Fisher Scientific International Inc., Hampton, New 
Hampshire, USA). Using the Benchmark XT automated immu­
nohistochemistry stainer (Ventana Medical Systems, Inc., Tuc­
son, AZ, USA), slides were stained using the following proce­
dure. The Ventana Ultraview DAB Kit (Ventana Medical Sys­
tems Inc., Tucson, Arizona, USA) was used for detection. Sec­
tions were deparaffinized using the EZ Prep solution contained 
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in this kit. CC1 standard (pH 8.4 buffer containing Tris, borate, 
and/EDTA) was used for antigen retrieval for 60 minutes at 
100°C. A DAB inhibitor (3% H2O2, endogenous peroxidase) 
was used for blocking for four minutes at 37°C. The slides were 
incubated with antibodies for collagen type III (Abcam Plc., 
Cambridge, Cambridgeshire, UK, diluted 1:100), laminin α4, 
and laminin α5 (Antibodies­online, Inc., Atlanta, Georgia, USA, 
diluted 1:100) for 32 minutes at 37°C, and a secondary antibody 
of universal horseradish peroxidase multimer for eight minutes 
at 37°C, followed by a DAB+H2O2 substrate for eight minutes 
and a hematoxylin and bluing reagent counterstain at 37°C. The 
reaction buffer (pH 7.6 Tris buffer) was used as a washing solu­
tion. After staining, the slides were mounted and evaluated with 
a Leica DMI3000 light microscope (Leica Microsystems, Wetz­
lar, Germany). In each case, a representative area was digitally 
captured, with an image size of 3,888 × 2,916 pixels, using a Lei­
ca DFC420 digital camera and saved in the JPG format. The re­
sulting images were analyzed using an I­solution image analyzer 
(IMT i­solution Inc., Vancouver, BC, Canada). Staining was quan­
tified via measurement of the percentage area of red pixels, re­
flecting one of the three monochromatic pixel values.
RESULTS
Enzyme-linked immunosorbent assay
Collagen type I, collagen type II, and fibronectin levels were 
slightly higher in the involuted IH samples than in the proliferat­
ing IH samples. However, these differences were not statistically 
significant. The median value (interquartile range) for the colla­
gen type III levels was 1.135 (0.946–1.486) in the involuted IH 
samples, compared to 1.008 (0.780–1.166) in the proliferating 
IH samples. This difference was statistically significant (P= 0.019). 
The median value (interquartile range) for the laminin levels was 
3.191 (2.945–3.191) in the involuted IH samples, compared to 
2.479 (1.699–3.284) in the proliferating IH samples. This dif­
ference was statistically significant (P = 0.047) (Fig. 1).
Histopathological findings
Proliferating IHs are unencapsulated aggregates of closely packed, 
thin­walled capillaries, in which an endothelial lining is usually 
present. Blood­filled vessels are separated by minimal connec­
tive tissue. Histology of the proliferating IH samples showed a 
marked proliferation of capillaries in a lobular configuration 
(Fig. 2A, B). Histology of the involuted IH samples showed an 
absence of vascular proliferation as well as fibrofatty residuum, 
progressive fibrosis, and fat replacement of vascular tissue in the 
subcutis (Fig. 3A, B). The expression of collagen III and laminin 
α4 and α5 were analyzed by immunohistochemistry and an I­
solution image analyzer. The expression of collagen III was sig­
nificantly greater in the involuted phase than in the proliferative 
phase. Red pixels with values of 70 and 190 occupied 40.4% and 
8.6% of the area of the slides, respectively (Figs. 2C, 3C). The 
expression of laminin α4 became diffuse and stronger along the 
basement membrane. The α4 chain staining was clearly present 
within the basement membrane adjacent to the vessels. The in­
tensity of staining in the basement membrane was significantly 
greater in the involuted phase than in the proliferative phase (Figs. 
2D, 3D). Red pixels ranging with values of 65 and 168 occupied 
14.2% and 4.8% of the area of the slides, respectively. However, 
the expression of laminin α5 was low in both phases, and no sig­
nificant difference was observed regarding the expression of lam­
inin α5 between the involuted and proliferating phases (Figs. 2E, 
3E). Red pixels with values of 63 and 171 occupied 7.7% and 
7.5% of the area of the slides, respectively.
DISCUSSION
In this study, we examined the composition of the ECM at dif­
ferent stages during the life cycle of IHs. We discovered that in­
voluted hemangiomas showed augmented production of colla­
gen III and laminin, as well as extensive deposition of α4 laminin 
within the basement membrane adjacent to the vessels. The me­
chanisms that initiate the involution of IHs remain largely un­
known. The increased apoptosis of endothelial cells and down­
regulated anti­apoptotic genes coincide with the onset of invo­
lution [7]. Aging progresses through a pathway involving apop­
tosis. Although it is still not clear whether the ECM regulates 
the apoptosis of cells in IHs, the different ECM compositions 
observed in our study suggest that laminin and collagen are re­
lated to the progression of IHs.
The collagens are the predominant proteins of the ECM [8]. 
Of the 28 different types of collagen, type I is the most abundant 
in the human body. Type III is the second most common colla­
gen in the body and is found in association with collagen type I. 
Collagen type III has a similar pattern of distribution to collagen 
type I, but the ratio of these two collagens varies from tissue to 
tissue [9]. A relatively high ratio of collagen type III to type I is 
found in the cardiovascular system [10]. In addition, the quanti­
ty of collagen as a component of the ECM changes with aging. 
During skin development, the quantity of collagen type III in 
the ECM of the skin gradually increases [9]. The ratio of colla­
gen type III to type I is related to aging and increases progres­
sively as a component of various biosynthetic processes [11]. 
Our findings indicate that increased levels of collagen type III 
are part of how the composition of the ECM changes during the 
progression of IHs. Moreover, our data showing an increased 
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Levels of collagen type III and laminin were significantly higher in 
involuted IHs than in proliferating IHs, which was a statistically sig-
nificant difference; P=0.019 and P=0.047, respectively. ECM, extra-
cellular matrix; IH, infantile hemangiomas. *P<0.05. 
Fig. 1. Quantitative comparisons of the composition of the ECM using ELISA
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deposition of collagen type III in involuted hemangiomas sug­
gest that collagen type III is linked to aging.
Fibronectin is a large protein and an abundant component of 
the ECM. The expression of fibronectin is up­regulated during 
angiogenesis [12]. During the first four decades of human life, 
plasma fibronectin levels continuously increase, which may be 
associated with the synthesis of many ECM proteins in the liver. 
In individuals 40–82 years old, quantitative fibrin­, heparin­, or 
collagen­binding domain epitope reactivity was found to rise 
continually, whereas the expression of the cell­binding and car­
boxyl­terminal fibronectin domain was found to be at nearly the 
same levels as in younger subjects. Senescence and the progres­
sive loss of bodily functions might be associated not only with 
age­dependent changes in plasma fibronectin molecular form 
but with the quantity of fibronectin [13]. In our study, we found 
no significant differences in fibronectin concentration between 
proliferating and involuted hemangiomas, suggesting that this 
parameter is independent of the phases of IH.
Laminins are composed of three different types of chains, α, β, 
and γ, which are usually found in the basement membrane. The 
trimeric combination of five α, four β, and three γ laminin chains 
results in a total of 15 different laminin isoforms. Laminins have 
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various sites for binding to receptors on the cell surface and to 
other ECM components, such as proteoglycans and collagens 
[8,14]. Vascular endothelial cells express two laminin chains, 
depending on the endothelial type and the phase of develop­
ment (e.g., growth or activation). These two isoforms, laminin 
α4 and laminin α5, are the major laminins found in vascular base­
ment membranes. These isoforms can combine with laminin 
β1 and γ1 chains in endothelial cell basement membranes to 
form laminin 8 and laminin 10, respectively. Laminin α4 is ex­
pressed by all vascular endothelial cells and is deposited in all 
(A) The proliferating phase is highly cellular with immature vessels (H&E, 
×200). (B) Relatively scant connective tissue is present in the prolifer-
ating phase (trichrome stain, ×200). (C) Anti-collagen III antibody was 
weakly stained (immunohistochemical stain, ×200). (D) Laminin α4 stain-
ing was not observed (immunohistochemical stain, ×200). (E) Laminin 
α5 antibody immunoreactivity was weakly present (immunohistochem-
ical stain, ×200).
Fig. 2. Histopathological findings characteristic of the proliferating phase
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(A) The involuted phase contains adipofibrous deposits and few remain-
ing vessels (H&E, ×200). (B) Higher levels of deposition of connective 
tissue, including collagen, are present (trichrome stain, ×200). (C) Tis-
sues immunostained with anti-collagen III antibody, demonstrating ex-
tensive staining (immunohistochemical stain, ×200). (D) The expression 
of anti-laminin α4 antibody is increased, especially in the basement mem-
brane (immunohistochemical stain, ×200). (E) The immunoreactivity of 
laminin α5 antibody was similar to that observed in the proliferating 
phase (immunohistochemical stain, ×200).
Fig. 3. Histopathological findings characteristic of the involuted phase 
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subendothelial basement membranes during all phases of vessel 
development. In contrast, laminin α5 is found primarily in the 
endothelial cell basement membranes of mature blood vessels, 
mostly in capillaries [14,15]. Increased laminin deposition may 
be related to the phase of vessel development. In our study, in­
voluted hemangiomas showed a higher quantity of laminin α4 
in the basement membrane. Our results are consistent with the 
hypothesis that the involution of IHs might be related to the up­
regulation of laminin α4 and, consequently, that involuted IHs 
may demonstrate extensive deposition of laminins. However, in 
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our study, the expression of laminin α5 was low in both phases, 
indicating that laminin α5 is not related to IH pathogenesis.
Vascular aging is associated with changes of both vascular func­
tion and structure that can take place at the level of vascular en­
dothelial cells, smooth muscle cells, and the ECM of blood ves­
sels [16]. One of the most relevant age­related vascular changes 
is a progressive intimal thickening composed of elongated cells 
and ECM accumulation with elastic tissue and collagen [17]. 
Similar to what is observed in large blood vessels, the age­related 
alteration of microvascular tone causes a progressive myogenic 
hypertrophic remodeling of small vessels, due to the altered dis­
tending pressure acting perpendicularly on the vessel wall [18,19]. 
Age­related changes in pericytes, the mural cells on capillaries, 
might also accelerate morphological and physiological deformi­
ties of the microvasculature. Age­related microvascular changes 
are characterized by broadening of the vessel and thickening of 
the basement membrane [20]. It has been found that basement 
membrane wall thickening is more frequent in vascular aging. 
This is consistent with our result that involuted hemangiomas 
showed a higher prevalence of thickening of the basement mem­
brane than proliferating hemangiomas. 
Aging is related to a decrease in the regenerative ability of en­
dothelial cells and endothelial senescence, which is character­
ized by an increase in the quantity of endothelial cell apoptosis 
[21]. Although the increased apoptosis of endothelial cells and 
downregulated anti­apoptotic genes have some distinct features 
related to IH regression [7], the mechanisms that regulate apop­
tosis in IHs remain poorly understood. Apoptosis is strictly con­
trolled by a complex interplay between B­cell lymphoma 2 pro­
teins, caspases, and procaspases. During the proliferating phase 
of IH, the apoptosis rate is low. However, in the involuted phase, 
the rate of apoptosis increases by a factor of five, while levels of 
the apoptosis­inhibiting protein B­cell lymphoma 2 decrease 
[22].
Many questions about the transition between the phases of IH 
remain unresolved. The hemangioma life cycle is associated 
with several changes in the composition of the ECM and the 
morphology of the basement membrane. Involuted hemangio­
mas were found to show extensive deposition of collagen III and 
laminin, as well as basement membrane wall thickening adjacent 
to blood vessels, although not much is known regarding the cau­
ses of these changes. Changes in the composition of the ECM 
are associated with the aging of IHs. These observations suggest 
that the ECM composition changes due to the rapid senescence 
of IHs. Further research is required to understand precisely how 
the ECM regulates the apoptosis and senescence of cells in IHs. 
This study provides some of the first data regarding differences 
in the ECM associated with senescence in IHs. 
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